Educational Needs of Healthcare Providers Managing Rheumatoid Arthritis: Global Survey

Which of the following best describes your profession? Other...

Which of the following best describes your specialty? *

Rheumatology

Internal medicine/primary care

Other...

Which of the following best describes your specialty? Other...

In what country are you currently practicing? *

How confident are you in your ability to utilize screening tools to recognize and diagnose RA EARLY in the course of disease progression? *

Please rank your confidence regarding your ability to utilize the following classes of disease modifying antirheumatic drugs (DMARDs) in clinical practice. *

(on a scale of 1 – 4, with 1 being the not confident and 4 being the very confident)

	1	2	3	4
Conventional synthetic DMARDs (e.g. methotrexate)	Conventional synthetic DMARDs (e.g. methotrexate) - 1	Conventional synthetic DMARDs (e.g. methotrexate) - 2	Conventional synthetic DMARDs (e.g. methotrexate) - 3	Conventional synthetic DMARDs (e.g. methotrexate) - 4
Tumor necrosis factor targeted monoclonal antibodies (mAB) (e.g. infliximab)	Tumor necrosis factor targeted monoclonal antibodies (mAB) (e.g. infliximab) - 1	Tumor necrosis factor targeted monoclonal antibodies (mAB) (e.g. infliximab) - 2	Tumor necrosis factor targeted monoclonal antibodies (mAB) (e.g. infliximab) - 3	Tumor necrosis factor targeted monoclonal antibodies (mAB) (e.g. infliximab) - 4
CD-20 directed monoclonal antibodies (e.g. rituximab)	CD-20 directed monoclonal antibodies (e.g. rituximab) - 1	CD-20 directed monoclonal antibodies (e.g. rituximab) - 2	CD-20 directed monoclonal antibodies (e.g. rituximab) - 3	CD-20 directed monoclonal antibodies (e.g. rituximab) - 4
CTLA-4 targeted therapy (e.g. abatacept)	CTLA-4 targeted therapy (e.g. abatacept) - 1	CTLA-4 targeted therapy (e.g. abatacept) - 2	CTLA-4 targeted therapy (e.g. abatacept) - 3	CTLA-4 targeted therapy (e.g. abatacept) - 4
Il-6 targeted monoclonal antibodies (e.g.tocilizumab)	Il-6 targeted monoclonal antibodies (e.g.tocilizumab) - 1	Il-6 targeted monoclonal antibodies (e.g.tocilizumab) - 2	Il-6 targeted monoclonal antibodies (e.g.tocilizumab) - 3	Il-6 targeted monoclonal antibodies (e.g.tocilizumab) - 4
JAK inhibitors (e.g. tofacitinib)	JAK inhibitors (e.g. tofacitinib) - 1	JAK inhibitors (e.g. tofacitinib) - 2	JAK inhibitors (e.g. tofacitinib) - 3	JAK inhibitors (e.g. tofacitinib) - 4

How familiar are you with the newest treatment recommendations relevant to the care of your patients with RA? *

Not familiar at all

Somewhat familiar

Moderately familiar

Very familiar

There are no relevant treatment recommendations for RA where I practice

Unsure if relevant treatment recommendations for RA are available where I practice

How knowledgeable are you about the available/emerging research and clinical trial data on investigational DMARDs? *

Not knowledgeable

Somewhat knowledgeable

Moderately knowledgeable

Very knowledgeable

How knowledgeable are you about available/emerging literature regarding the role of cytokines and cytokine signaling in the pathogenesis and treatment of RA? *

Not knowledgeable

Somewhat knowledgeable

Moderately knowledgeable

Very knowledgeable

Which of the following BEST describes your next step in treatment for a RA patient displaying an inadequate response to a TNF inhibitor? *

Continue treatment as is and reassess for improvement periodically

Switch the patient to a different TNF inhibitor

Switch the patient to a CD20 mAB

Switch the patient to a CTLA-4 therapy

Switch the patient to a Il-6 mAB

Switch the patient to a JAK inhibitor

Unsure

Other...

Which of the following BEST describes your next step in treatment for a RA patient displaying an inadequate response to a TNF inhibitor? Other...

How confident are you in your ability to evaluate patient- and disease- specific factors to select an optimal DMARD therapy among all available agents/classes? *

Not confident

Somewhat confident

Moderately confident

Very confident

What are your most significant educational needs regarding the diagnosis, treatment and overall management of your patients with RA? *

If you are interested in participating in the raffle for a $100 Amazon gift card, please fill out the following:

First Name:

Last Name:

Email:

You are here

Educational Needs of Healthcare Providers Managing Rheumatoid Arthritis: Global Survey